Kenvue (NYSE:KVUE) shares may see some relief on Monday after they dropped 7.3% last week amid a court filing late Friday in a class action lawsuit alleging prenatal exposure to Tylenol caused a child's autism, according to a UBS note.
Kenvue (NYSE:KVUE) shares may see some relief on Monday after they dropped 7.3% last week amid a court filing late Friday in a class action lawsuit alleging prenatal exposure to Tylenol caused a child's autism, according to a UBS note.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.